← FDA Drug Approvals (Drugs@FDA)

TOPIRAMATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZHEJIANG POLY PHARM CO LTD · Approved 2026-06-29

Drug application

FDA Application #

ANDA219207

Application type

Abbreviated New Drug Application (Generic)

Brand name

TOPIRAMATE

Generic name

Topiramate

Active ingredients

TOPIRAMATE

Dosage form

CAPSULE, EXTENDED RELEASE

Route

—

Marketing status

None (Tentative Approval)

Sponsor

ZHEJIANG POLY PHARM CO LTD

First approval

2026-06-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown